Organisation paid for research Program year 2024 Source: CMS Open Payments

Phoenix Clinical Research

Neither a doctor nor a teaching hospital

Research payments

$857,795

315 payments

Through program year 2024, Phoenix Clinical Research is reported as receiving $857,795 in research payments, across 315 payments.

By program year

5 rows

Year	Kind	Amount	Payments
2024	Research	$149,200	264
2023	Research	$8,100	4
2022	Research	$6,500	6
2020	Research	$351,173	27
2019	Research	$342,822	14

Breakdown

Who paid Research payments · program years 2019–2024

Heron Therapeutics, Inc. $693,995 41 payments
Novo Nordisk Inc $137,700 261 payments
Zimmer Biomet Holdings, Inc. $14,600 10 payments
GlaxoSmithKline, LLC. $11,500 3 payments

Studies the money was for Research payments · program years 2019–2024

Total Knee Arthroplasty (TKA) Study of HTX-011 in an Multimodal Analgesic Regimen (MMA) Regimen $342,822 14 payments
A Phase 4, Open-Label Study of Liposomal Bupivacaine Admixed With Bupivacaine HCl in Subjects Undergoing Total Knee Arthroplasty $181,502 14 payments
Total Knee Arthroplasty (TKA) Study of HTX-011 in an Multimodal Analgesic Regimen (MMA) Regimen $164,451 12 payments
Das-7537 $137,700 261 payments
A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Gr $11,500 3 payments
Berkowitz, Richard, 04-500, TM Stem CSI 90-202 $11,400 8 payments
Total Knee Arthroplasty Infiltration Study for Postoperative Analgesia $5,220 1 payment
CME2016-105H, Trilogy Survey $3,200 2 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.